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Abstract
Objectives. To assess the societal cost-effectiveness of the Transmural Trauma Care Model
(TTCM), a multidisciplinary transmural rehabilitation model for trauma patients, compared
with regular care.
Methods. The economic evaluation was performed alongside a before-and-after study, with a
convenience control group measured only afterward, and a 9-month follow-up. Control group
patients received regular care and were measured before implementation of the TTCM.
Intervention group patients received the TTCM and were measured after its implementation.
The primary outcome was generic health-related quality of life (HR-QOL). Secondary out-
comes included disease-specific HR-QOL, pain, functional status, and perceived recovery.
Results. Eighty-three trauma patients were included in the intervention group and fifty-seven
in the control group. Total societal costs were lower in the intervention group than in the con-
trol group, but not statistically significantly so (EUR-267; 95 percent confidence interval [CI],
EUR-4,175–3011). At 9 months, there was no statistically significant between-group differ-
ences in generic HR-QOL (0.05;95 percent CI, −0.02–0.12) and perceived recovery (0.09;95
percent CI, −0.09–0.28). However, mean between-group differences were statistically signifi-
cantly in favor of the intervention group for disease-specific HR-QOL (−8.2;95 percent CI,
−15.0–−1.4), pain (−0.84;95CI, −1.42–−0.26), and functional status (−20.1;95 percent CI,
−29.6–−10.7). Cost-effectiveness acceptability curves indicated that if decision makers are
not willing to pay anything per unit of effect gained, the TTCM has a 0.54–0.58 probability
of being cost-effective compared with regular care. For all outcomes, this probability increased
with increasing values of willingness-to-pay.
Conclusions. The TTCM may be cost-effective compared with regular care, depending on the
decision-makers willingness to pay and the probability of cost-effectiveness that they perceive
as acceptable.
Traumatic injury is the leading cause of death during the first 4 decades of life, accounts for 9.6
percent of global mortality (1;2), and causes the biggest loss of disability-adjusted life-years
compared with any other disease (3). Traumatic injury disproportionately affects younger indi-
viduals and, as a consequence, accounts for the highest amount of lost productive years of life
(4). While the direct medical costs of traumatic injury are substantial, its economic burden is
particularly high for employers. To illustrate, in the United States, the total cost of fatal unin-
tentional injury was estimated at approximately USD84 billion, of which the largest share was
due to lost productivity (i.e., approximately USD83 billion) (4). In the Netherlands, the total
cost of trauma (intentional and unintentional) was estimated to be EUR6 billion, of which
EUR2.6 billion were direct medical costs and EUR3.4 billion were lost productivity costs (5).
During the past 3 decades, an improved organization of acute trauma care has led to a 15
percent to 25 percent decrease in mortality (6–8). As further improvements in survival rates
are likely to be relatively small, the focus of trauma care has moved from reducing mortality
to improving quality of life and outcome (9). A possible means for improving trauma patients’
health-related quality of life (HR-QOL) and outcome may be the optimization of their reha-
bilitation process. We, therefore, developed the Transmural Trauma Care Model (TTCM),
which aims to improve the organization, content, and quality of the trauma patients’ rehabil-
itation process. The TTCM consists of a continuous feedback loop, in which a
https://doi.org/10.1017/S0266462319000436
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multidisciplinary hospital-based team supervises a network of pri-
mary care physical therapists in the treatment of trauma patients
(10). Effectiveness analyses showed that, among trauma patients
with at least one fracture, the TTCM resulted in better patient out-
comes, such as disease-specific HR-QOL, pain, and functional
status, compared with regular care (Wiertsema et al., unpublished
data).
As healthcare resources are restricted, trauma systems should
not only be effective in improving patient outcomes, but also pro-
vide “good value for money.” The latter is assessed in an eco-
nomic evaluation, which provides insight into a treatment’s
additional cost per additional unit of health gained (11). Up
until now, relatively few economic evaluations evaluated the cost-
effectiveness of trauma systems (12–14), and those aimed at the
rehabilitation phase in particular. Therefore, the current eco-
nomic evaluation aimed to assess the cost-effectiveness of the
TTCM for generic HR-QOL from a societal perspective compared
with regular care. In a secondary analysis, the intervention’s cost-
effectiveness for disease-specific HR-QOL, pain, functional status,
and perceived recovery was assessed.
Methods
The study protocol has been published elsewhere (10). A sum-
mary is given below.
Design
The economic evaluation was conducted alongside a
before-and-after study with a convenience control group mea-
sured only afterward. This clinical trial was conducted at the out-
patient clinic of a level-1 trauma center (Amsterdam UMC,
location VUmc, Amsterdam, the Netherlands) (15). In contrast
to a true controlled-before-and-after study, only the intervention
group was prospectively followed, while control group data were
collected cross-sectionally. That is, the trial’s control group con-
sisted of four independent clusters of patients who either had
their first consultation at the outpatient clinic 0, 3, 6, or 9 months
ago. After implementation of the TTCM, one cluster of interven-
tion group patients was prospectively followed and measured
directly after their first consultation at the outpatient clinic (i.e.,
baseline), and after 3, 6, and 9 months (Figure 1). To capture
all costs flowing from the intervention under study, the analytic
time frame of an economic evaluation typically needs to be longer
than that of an effectiveness study (16). Therefore, in the present
economic evaluation, only the 9-month control cluster was com-
pared with the intervention group. The 9-month control cluster
will be further referred to as the control group.
The medical ethics committee of the VUmc decided that the
Dutch Medical Research Involving Human Subjects Act
(WMO) was not applicable to the present study (registered
under number 2013.454). All participants gave informed consent.
The trial is registered at the Dutch Trial Register (NTR5474).
Participants
Surgically as well as conservatively treated trauma patients were
included. Eligible trauma patients had at least one traumatic frac-
ture, were aged ≥18 years, rehabilitated in the primary care set-
ting, and were able to fill out online questionnaires in Dutch.
Patients were excluded if they met any of the following criteria:
traumatic brain injury, pathological (nontraumatic) fractures,
cognitive limitations, rehabilitation in a tertiary care facility, or
living outside the catchment area of the VUmc.
Control group patients were identified from the central trauma
registry of the trauma region “North West Netherlands” and were
contacted by phone by one of the investigators. They received fur-
ther information about the study, after which the principle inves-
tigator verified the in- and exclusion criteria and patients were
assigned to their specific cluster (based on the time elapsed
since their first consultation). Eligible patients who were willing
to participate received an email containing a link to the online
questionnaire. Patients who did not respond within one week
received a maximum of two reminder emails. If the patient did
not reply to both emails, one of the coordinating investigators
contacted the patient by phone.
Intervention group patients were identified during their first
consultation at the outpatient clinic. During this consultation,
patients were informed about the study by one of the investigators
and in- and exclusion criteria were verified. In the week following
the first consultation, patients who were willing and eligible to
participate, received an email containing a link to the first online
questionnaire. Subsequently, patients were prospectively followed
and received additional online questionnaires at 3-, 6-, and
9-month follow-up. Patients who did not respond within 1
week, received a maximum of two reminder emails. If the patient
did not reply to both emails, one of the coordinating investigators
contacted the patient by phone.
Intervention Conditions
Pre- and in-hospital trauma care remained unchanged and was
the same for the intervention group and the control group.
The TTCM
Patients in the intervention group received care according to the
TTCM (10). The TTCM combined the following components:
A multidisciplinary team consisting of a trauma surgeon and a
highly-specialized hospital-based trauma physical therapist at
the outpatient clinic for trauma patients
The trauma surgeon acted as the chief consultant, the physical
therapist assessed physical function and acted as case manager
throughout the rehabilitation process. During a shared decision-
making process, the surgeon, physical therapist, and patient deter-
mined whether and when physical therapy in primary care was
required.
Coordination and individual goal setting for each patient by this
hospital-based team in combination with treatment according
to customized protocols
The hospital-based team coordinated the patients’ rehabilitation
process by repeatedly defining individual goals with the patient
during the rehabilitation period. For the purpose of the TTCM,
ten rehabilitation protocols were developed for the most common
fractures (e.g., hip fractures, tibial plateau fractures).
A network of forty specialized primary care physical therapists
This so called “VUmc trauma rehabilitation network” consisted of
forty physical therapists covering the region of Amsterdam (www.
traumarevalidatie.nl) (17). The forty primary care physical thera-
pists participating in the trauma network were trained and
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educated during a 2-day course led by trauma surgeons and
hospital-based physical therapists, specialized in trauma care.
E-health support for transmural communication between the
hospital-based trauma physical therapist and the primary care
physical therapist
The hospital-based physical therapist and the primary care phys-
ical therapist communicated repeatedly throughout the rehabilita-
tion process using secured email (especially developed for
healthcare professionals).
Regular Care
Patients in the control group received regular postclinical care
during which the trauma surgeon acted as the chief consultant
and performed the postclinical consultations, unaccompanied
by any allied health care professionals. The trauma surgeon
decided whether and when physical therapy in primary care
was needed. During a patients’ rehabilitation, there was no regular
contact between the surgeon and the primary care physical
therapist.
Outcome Measures
Various demographic and trauma-related characteristics were
assessed for all patients (e.g., age, gender, medical history,
Injury Severity Score [ISS], time between trauma and first outpa-
tient consultation [TTO]). These characteristics were collected
using online questionnaires, supplemented by data derived from
electronic patient records.
The primary outcome was generic HR-QOL. Secondary out-
comes included disease-specific HR-QOL, pain, functional status,
and perceived recovery. In the intervention group, outcome mea-
sures were assessed at 0, 3, 6, and 9 months after patients’ first
consultation at the outpatient clinic. In the control group,
outcome measures were solely assessed at 9 months after the
patients’ first consultation at the outpatient clinic.
Generic HR-QOL was measured using the EQ-5D-3L (18).
Using the Dutch tariff, the participants’ EQ-5D-3L health states
were converted into a utility score, anchored at 0 (dead) and 1
(optimal health). As control group participants were only mea-
sured once, we were not able to estimate quality-adjusted life-
years and include them as an outcome measure in the current
economic evaluation. Nonetheless, generic HR-QOL can still be
regarded as a preference-based measure, as utility values were
based on the preferences of the Dutch population.
Disease-specific HR-QOL was measured using four
disease-specific function scales, appropriate to the patients’ spe-
cific injury type. The Quick Dash score was filled out by patients
with fractures of the upper extremity (19;20). The Lower
Extremity Functional Scale (LEFS) was used in patients with
hip fractures or other lower extremity fractures (21;22). The
Roland Morris Disability Score (RMDS) was filled out by patients
with vertebral fractures (23;24). The Groningen Activity
Restriction Scale (GARS) was used in multi trauma patients
(25). An overall disease-specific HR-QOL score was calculated
by converting the overall scores of the four above-mentioned
questionnaires to a scale from 0–100, with higher scores repre-
senting more functional problems.
Pain was measured using an 11-point numeric pain rating scale
(NPRS), ranging from 0 (no pain) to 10 (worst possible pain) (26).
Functional status was measured using the Patient Specific
Function Scale (PSFS) (27;28). Patients had to identify three
important activities that they are having difficulty with and
were requested to rate their current level of difficulty associated
with each activity on an 0–100 mm visual analogue scale (VAS)
ranging from 0 (“able to perform activity at same level as before
injury or problem”) to 100 (“unable to perform activity”). Only
the activity that was first mentioned by the patient was used in
the economic evaluation.
Fig. 1. Study design of the modified controlled before and after study.
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Perceived recoverywasmeasuredusing theGlobal PerceivedEffect
(GPE) scale. Patientswere asked to rate howmuch their conditionhas
improved or deteriorated since their trauma on a seven-item scale
(29). Success of treatment was achieved when a patient reported to
being “completely recovered” or “much improved.”
Cost Measures
Costs were measured from a societal perspective, including inter-
vention, health care, absenteeism, presenteeism, and unpaid pro-
ductivity costs. Intervention costs included all costs related to the
additional time investments of the hospital-based trauma physical
therapist (estimated at 15 minutes per outpatient clinic consulta-
tion) and the specialized primary care physical therapist (estimated
at 5minutes per outpatient clinic consultation), as well as the cost of
hosting and maintaining the transmural communication system.
The costs associated with the TTCM’s development (e.g., training
costs) were excluded, as these costs will become negligible after
implementing the intervention broadly (30;31). All other cost cate-
gories were assessed using online cost questionnaires, supple-
mented by hospital records if available (e.g., for imaging
procedures). To cover the complete duration of follow-up, recall
periods of the online questionnaires varied between treatment
groups and measurement points. For the intervention group,
3-month recall periods were used at baseline, 3, 6, and 9 months
follow-up and costs were added together to get an estimate of the
total costs during the 9-month follow-up period. For the control
group, a recall period of 9 months was used at 9-month follow-up.
Healthcare use included the use of primary care (e.g., consul-
tations at the general practitioner or physical therapist) and sec-
ondary care (e.g., consultations at the outpatient clinic for
trauma patients, hospitalization) as well as the use of medication.
Dutch standard costs were used to value healthcare costs (31).
Medication use was valued using the G-standard of the Dutch
Society of Pharmacy (32).
Absenteeism was assessed using the “PROductivity and DISease
Questionnaire” (PRODISQ). Patients were asked to report their
total number of sick leave days (33). Absenteeism was valued using
age- and gender-specific price weights (31).
Presenteeism was defined as reduced productivity while at work
and was assessed using the World Health Organization Health and
Work Performance Questionnaire (34). Presenteeism was valued
using age- and gender-specific price weights (31).
Unpaid productivity losses were assessed by asking patients for
how many hours per week they were unable to perform unpaid
activities, such as domestic work, school, and voluntary work. A
recommended Dutch shadow price was used to value unpaid pro-
ductivity. The Dutch shadow price was calculated in accordance
with the opportunity good method and was estimated to be
EUR12.50 per hour in 2009 (31).
All costs were presented in Euros and converted to the same
reference year (i.e., 2014) using consumer price indices.




Descriptive statistics were used to compare baseline characteristics
between intervention and control group participants.
Handling Missing Data
Missing data were imputed using Multiple Imputation by Chained
Equations (35). Two imputation models were constructed, includ-
ing one for the intervention group and one for the control group.
Both imputation models included variables related to the “missing-
ness” of data, variables that predicted the outcomes, and all available
midpoint and follow-up cost and effect measure values (35). Ten
complete data sets were created in order for the loss-of-efficiency
to be below 5 percent (36). Imputed datasets were analysed sepa-
rately as specified below, after which pooled estimates were calcu-
lated using Rubin’s rules (36).
Economic Evaluation
Cost-effectiveness analyses were performed according to the
intention-to-treat principle. Cost and effect differences were esti-
mated using seemingly unrelated regression analyses to correct for
their possible correlation. Cost and effect differences were cor-
rected for confounders. Confounding was checked by adding
the potential confounding variable to the crude models, and
was subsequently considered to be present if the regression coef-
ficient changed by 10 percent or more. To deal with the highly
skewed nature of cost data, 95 percent confidence intervals around
the differences in costs were estimated using the bias corrected
and accelerated bootstrap method, with 5,000 replications.
Incremental cost-effectiveness ratios (ICERs) were calculated by
dividing the differences in costs by those in effects. To graphically
illustrate the uncertainty surrounding the ICERs, bootstrapped
incremental cost-effect pairs were plotted on cost-effectiveness
planes (37).
A summary measure of the joint uncertainty of costs and
effects was presented using cost-effectiveness acceptability curves
(CEACs), which indicate the probability of an intervention being
cost-effective in comparison with the control condition for a
range of willingness-to-pay values (i.e., the maximum amount
of money decision makers are willing to pay to gain one extra
unit of effect) (38). Two one-way structural sensitivity analyses
were performed to test the robustness of the results: (i) applying
the healthcare perspective (i.e., only costs accruing to the Dutch
healthcare system were included), and (ii) excluding presenteeism
costs (11). All analyses were performed in STATA, using a level of
significance of p < .05.
Results
Study Participants
Eighty-three trauma patients were enrolled in the intervention
group and 57 in the control group (Supplementary Figure 1).
Most baseline characteristics were similar among intervention
and control group patients. However, patients in the intervention
group were slightly younger, were more frequently admitted to a
hospital, received surgery more frequently, and had a longer time
between trauma and their first outpatient consultation than their
control group counterparts (Table 1). A total of 107 patients (76
percent) had complete effect data at 9 months follow-up (i.e., 52
intervention group patients and 55 control group patients) and 62
patients (44 percent) had complete cost data on all measurement
points (i.e., seventeen intervention group patients and forty-five
control group patients).
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Effectiveness
At 9 months, there was no statistically significant difference in
the primary outcome generic HR-QOL between the interven-
tion group and control group. As for the secondary outcomes,
mean between-group differences were statistically significantly
in favor of the intervention group for disease-specific
HR-QOL, pain, and functional status, but not for perceived
recovery (Table 2).
Costs
On average, the cost of the TTCM was EUR272 (SEM = EUR4)
per patient. Secondary healthcare, presenteeism, and total societal
costs were lower in the intervention group than in the control
group, while primary healthcare, medication, absenteeism, and
unpaid productivity costs were higher in the intervention group
than in the control group. Of them, only the difference in second-
ary healthcare costs was statistically significant (Table 3).
Economic Evaluation
Primary Outcome. Generic HR-QOL
The main analysis results for generic HR-QOL indicated that the
TTCM dominated regular care (i.e., less costly and more effective)
(Table 2). The CEAC in Supplementary Figure 2 indicates that the
TTCM has a 0.58 probability of being cost-effective compared
with usual care if decision makers are not willing to pay anything
per utility gained, increasing to a maximum of 0.90 at a
willingness-to-pay of EUR55,000/utility gained.
Secondary Outcomes. Disease-Specific HR-QOL, Pain, Perceived
Recovery, and Functional Status
The main analysis results for disease-specific HR-QOL indicated
that the TTCM dominated regular care (i.e., less costly and more
effective) (Table 2). Please note that a lower score in
disease-specific HR-QOL indicates an improvement. The CEAC
in Supplementary Figure 2 indicates that the TTCM has a 0.55
probability of being cost-effective compared with regular care if
Table 1. Baseline Characteristics (Patient- and Trauma Related)
Characteristics
Intervention group Control group
Mean (SD) or frequency (%) Mean (SD) or frequency (%)
N 83 57
Age 43.4 (15.6) 50.5 (17.9)
Gender (M/F) 39/44 (47/53%) 26/31 (46/54%)
Education level
Low 7 (8.4%) 6 (11.1%)
Middle 19 (22.9%) 16 (29.6%)
High 57 (68.7%) 32 (59.3%)
Medical history
None 53 (63.9%) 30 (52.6%)
Chronic 14 (16.9%) 13 (22.8%)
Musculoskeletal 16 (19.3%) 14 (24.6%)
Trauma type
Traffic 44 (53.0%) 25 (43.9%)
Work related 0 2 (3.5%)
Fall 27 (32.5%) 17 (29.8%)
Sports 11 (13.3%) 9 (15.8%)
Other 1 (1.2%) 4 (7.0%)
Fracture region
Upper extremity 31 (37.3%) 25 (43.9%)
Lower extremity 41 (49.4%) 19 (33.0%)
Vertebral 7 (8.4%) 1 (1.8%)
Multitrauma 4 (4.8%) 12 (21.1%)
ISS 7.9 (range 4-26, SD 4.4) 8.6 (range 4-29, SD 6.3)
Admission hospital 62 (75%) 29 (51%)
Length of stay 7.1 (6.1) 10.0 (11.4)
Surgery 53 (64%) 21 (37%)
TTO (days) 24.3 (14.3) 14.6 (14.7)
M/F, male/female; SD, standard deviation; TTO, time between trauma and first outpatient consultation.
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Table 2. Differences in Pooled Mean Costs and Effects (95% CI), ICERs, and the Distribution of Incremental Cost-Effect Pairs around the Quadrants of the CE Planes
Sample size
ΔC (95% CI)a ΔE (95% CI)b ICER
Distribution CE-plane (%)
Analysis Intervention group Control group Outcome EUR Points EUR/point NEc SEd SWe NWf
Main analysis 83 57 Generic HR-QOL (0-1) −237 (−4286 to 3285) 0.05 (−0.02 to 0.12) −4453 40.7 53.4 2.2 3.7
Imputed dataset 83 57 Disease-specific HR-QOL (0-100) −232 (−4342 to 3167) −8.2 (−15.0 to −1.4) 28 39.6 53.5 2.0 5.0
83 57 Pain (0-10) −190 (−4140 to 3284) −0.84 (−1.42 to −0.26) 225 45.1 54.7 0.0 0.1
83 57 Perceived recovery (0-1) −192 (−4348 to 3112) 0.09 (−0.09 to 0.28) 2087 36.9 48.2 0.9 0.6
83 57 Functional status (0-100) −345 (−4372 to 3121) −20.1 (−29.6 to −10.7) 17 42.7 57.3 0.0 0.0
One-way 83 57 Generic HR-QOL (0-1) −491 (−2700 to 393) 0.05 (−0.02 to 0.12) 19 24.3 69.5 0.4 0.2
sensitivity analysis 1 83 57 Disease-specific HR-QOL (0-100) −466 (−2698 to 317) −8.2 (−15.0 to −1.4) 57 21.0 68.1 5.1 5.9
Healthcare perspective 83 57 Pain (0-10) −490 (−2780 to 391) −0.84 (−1.44 to −0.25) 580 26.4 73.5 0.1 0.0
83 57 Perceived recovery (0-1) −454 (−2570 to 412) 0.09 (−0.08 to 0.25) 5725 20.1 62.8 10.4 6.7
83 57 Functional status (0-100) −511 (−2749 to 391) −20.1 (−29.6 to −10.7) 25 24.5 74.5 0.0 0.0
One-way 83 57 Generic HR-QOL (0-1) 339 (−4237 to 4216) 0.05 (−0.02 to 0.12) 6371 52.0 42.1 1.7 4.2
sensitivity analysis 2 83 57 Disease-specific HR-QOL (0-100) 351 (−4222 to 4152) −8.2 (−15.0 to −1.4) −43 50.6 41.6 2.0 5.7
Excluding presenteeism 83 57 Pain (0-10) 373 (−4142 to 4179) −0.84 (−1.44 to −0.25) −441 56.9 42.9 0.0 0.1
83 57 Perceived recovery (0-1) 393 (−4327 to 4283) 0.09 (−0.08 to 0.25) 4328 48.9 36.4 6.2 8.5
83 57 Functional status (0-100) 224 (−4340 to 4045) −20.1 (−29.6 to −10.7) −11 54.7 45.3 0.0 0.0
CE, cost-effectiveness; CI, confidence interval; EUR, Euro; HR-QOL, health-related quality of life; ICER, incremental cost-effectiveness ratio; TTO, time between trauma and first outpatient consultation.
Note. Please note that the mean cost differences differ across outcomes. This is due to the use of Seemingly Unrelated Regression analyses, in which cost and effect differences are corrected from their possible correlation.
aCost differences were corrected for medical history, surgery, paid work (yes/no), and number of working hours/week.
bEffect differences were corrected for age, medical history, TTO (Generic HR-QOL); age, medical history, TTO, fracture region, admission hospital, surgery (Disease-specific HR-QOL); none (Pain); medical history, TTO (Perceived recovery) and TTO,
surgery (Functional status).
cRefers to the northeast quadrant of the CE-plane, indicating that the intervention is more effective and more costly than usual care.
dRefers to the southeast quadrant of the CE-plane, indicating that the intervention is more effective and less costly than usual care.
eRefers to the southwest quadrant of the CE-plane, indicating that the intervention is less effective and less costly than usual care.
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decision makers are not willing to pay anything per one-point
improvement in disease-specific HR-QOL, increasing to 0.95 at
a willingness-to-pay of EUR700/point improvement.
The main analysis results for pain indicated that the TTCM
dominated regular care (i.e., less costly and more effective)
(Table 2). Please note that a lower pain score indicates an
improvement. The CEAC in Supplementary Figure 2 indicates
that the TTCM has a 0.54 probability of being cost-effective com-
pared with regular care if decision makers are not willing to pay
anything per one-point improvement in pain, increasing to 0.95
at a willingness-to-pay of EUR3500/point improvement.
The main analysis results for perceived recovery indicated that
the TTCM dominated regular care (i.e., less costly and more effec-
tive) (Table 2). The CEAC in Supplementary Figure 2 indicates
that the TTCM has a 0.54 probability of being cost-effective com-
pared with regular care if decision makers are not willing to pay
anything per recovered patient, increasing to a maximum of
0.85 at a willingness-to-pay of EUR50,000/recovered patient.
The main analysis results for functional status indicated that the
TTCM dominated regular care (i.e., less costly and more effective)
(Table 2). Please note that a lower score in functional status indi-
cates an improvement The CEAC in Supplementary Figure 2 indi-
cates that the TTCM has a 0.57 probability of being cost-effective
compared with regular care if decision makers are not willing to
pay anything per point improvement in functional status, increas-
ing to 0.95 at a willingness-to-pay of EUR125/point improvement.
One-Way Sensitivity Analyses
When the healthcare perspective was applied, the mean difference
in total costs was larger than in the main analysis (e.g., EUR-491
versus EUR-237 for general HR-QOL), and still in favor of the
intervention group. This resulted in higher probabilities of the
TTCM being cost-effective compared with the main analysis
(Table 2). When excluding presenteeism costs, total costs were
higher in the intervention group than in the control group.
This finding was in contrast to the main analysis, and resulted
in lower probabilities of the TTCM being cost-effective (Table 2).
Discussion
Traumatic injury is the most important cause of long-term func-
tional limitations in adults younger than 45 years (39) and poses a
substantial economic burden to society (40). As healthcare
resources are restricted, trauma systems should not only be effec-
tive in improving patient outcomes, but also provide “good value
for money”. Therefore, the current economic evaluation aimed to
assess the cost-effectiveness of the TTCM for generic HR-QOL
from a societal perspective compared with regular care. In a sec-
ondary analysis, the intervention’s cost-effectiveness for
disease-specific HR-QOL, pain, functional status, and perceived
recovery was assessed.
Main Findings
Results indicated that the TTCM statistically significantly
improved disease-specific HR-QOL, pain, and functional status
compared with regular care. Between-group differences in generic
HR-QOL, perceived recovery, and total costs were in favor of the
intervention group as well, but not statistically significantly so. On
average, the TTCM dominated regular care for all outcomes.
CEACs indicated that if decision makers are not willing to pay
anything per unit of effect gained, the TTCM has a 0.54–0.58
probability of being cost-effective compared with usual practice.
For all outcomes, this probability increased to relatively high levels
with increasing values of willingness-to-pay (e.g., to 0.95 at a
willingness-to-pay of EUR700/point improvement on a NRS).
However, as it is unknown what decision makers are currently
willing-to-pay per unit of effect gained, strong conclusions cannot
be made about the cost-effectiveness of the TTCM. Nonetheless,
decision makers need to understand the role that rehabilitation,
job retraining, and injury prevention play in dealing with the tre-
mendous economic impact of traumatic injury to society and they
can use the present results to consider whether the TTCM pro-
vides “good value for money” at an acceptable probability of
cost-effectiveness.
Comparison with the Literature
Even though extensive research has been done on the quality and
organization of pre- and in-hospital trauma care, relatively few
economic evaluations have evaluated the cost-effectiveness of
regionalized trauma systems (12–14), and those aimed at the
rehabilitation phase in particular. A recent study assessed the
cost-effectiveness of several care pathways for inpatient rehabilita-
tion in severe trauma patients (41). All participants were treated
Table 3. Mean Costs per Participant inI and Control Groups and Mean Cost Differences between Groups during the 9-Month Follow-up Period
Cost category
Intervention group n =
83; mean (SEM) EUR




Mean cost difference Adjusted
(95%CI) EUR
Intervention 272 (4) 0 (0) 272 (257 to 278) 270 (264 to 277)
Healthcare 2,397 (174) 3,003 (639) −606 (−2821 to 218) −953 (−3854 to 168)
Primary health care 1,138 (108) 925 (152) 212 (−175 to 559) 56 (−440 to 494)
Secondary health care 1,216 (112) 2,005 (567) −789 (−2853 to -119) −1,010 (−3696 to -67)
Medication 44 (14) 74 (21) −29 (−90 to 14) 1 (−65 to 87)
Absenteeism 7,052 (1253) 3,419 (1149) 3,633 (503 to 6292) 595 (−3072 to 3564)
Presenteeism 2,692 (559) 2,274 (533) 418 (−937 to 1679) −565 (−1769 to 666)
Unpaid productivity 1,408 (250) 1,214 (273) 194 (−483 to 880) 283 (−645 to 1305)
Total 13,822 (1261) 9,910 (1475) 3912 (−457 to 6860) −267 (−4175 to 3011)
CI, confidence interval; EUR, Euro; SEM, standard error of the mean.
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in a specialized trauma hospital, but the group that rehabilitated
in an in-hospital rehabilitation center, had a significantly shorter
length of stay (LOS) compared with the group that rehabilitated in
an external rehabilitation center. However, this was a retrospective
cohort study that solely used LOS as a proxy for resource con-
sumption and, therefore, cannot be considered as a full economic
evaluation. Furthermore, a Dutch study evaluated an integrated
inpatient “Fast Track” rehabilitation service for multi trauma
patients.
No significant effect differences were observed between the
intervention and control group and results of the scheduled eco-
nomic evaluation have not yet been published (42). Another
study evaluated the cost-effectiveness of three inpatient rehabilita-
tion modalities (i.e., physically orientated, geriatrically orientated,
and routine treatment) in patients with hip fractures. Considering
total costs 1 year after trauma, physically orientated rehabilitation
showed to be more cost-effective than routine treatment.
Although it was a robust study, the results were not generalizable
to other trauma patients (43). To the best of our knowledge, the pre-
sent study is the first to evaluate the cost-effectiveness of a transmu-
ral care model for the postclinical rehabilitation of trauma patients.
Strengths and Weaknesses of the Study
Important strengths of this study are the fact that it was the first to
evaluate the cost-effectiveness of a new multidisciplinary trans-
mural rehabilitation model for trauma patients, its use of a control
group and its pragmatic design (i.e., daily practice is resembled as
much as possible). Also, the study population covers a broad
range in trauma patients (ISS ranging from 4 to 43). This is an
important strength, as the majority of studies assessing
HR-QOL, functional outcomes and costs after trauma, included
only major trauma patients with an ISS > 16 (39;44;45) or trauma
patients with specific injuries (e.g., hip fractures or vertebral frac-
tures) (46). As our study population represents the whole spec-
trum from mild to severely injured trauma patients, the results
are likely to be generalizable to the total trauma patient popula-
tion (except patients with traumatic brain injury, which were
excluded in this study). However, future research is necessary to
explore whether specific trauma patient subgroups respond in a
different way on the TTCM.
The study also had some limitations. First, a controlled-before-
and-after design, with a convenience control group measured only
afterward, was regarded as the most optimal research design within
the available resources and within the possibilities of clinical prac-
tice. However, such nonrandomized study designs are inherently
susceptible to many types of bias, such as selection bias, recall
bias, regression to the mean, the Hawthorne effect, and repeat
testing bias (47). Most likely in the present study is the occurrence
of selection bias, meaning that the control group and intervention
group are likely to differ in known and unknown etiological fac-
tors. As a consequence, it is not possible to rule out the possibility
that the current findings are biased by baseline differences in
group characteristics, and those that we were not able to measure
due to the current study design in particular (15). Even though we
were able to correct for some of them in our analyses, a random-
ized controlled design or an observational design with a propen-
sity score matched control group would have likely produced
more valid results. Among others, this is evidenced by the fact
that after correcting the total cost difference for medical history,
surgery, paid work, and working hours it changed from being
positive to negative, albeit not statistically significant in both
cases.
Another potential form of bias is the possible influence of
recall bias due to the use of retrospective questionnaires with
varying recall periods. The assumption is that a longer recall
period increases the change of recall bias due to difficulties in rec-
ollecting facts and events after an elongated period of time. As
control group patients were asked to remember their resource
use during the last 9 months instead of during the past 3 months
(which was the case for the intervention group), one might argue
that the costs of the control group have a higher probability of
being underestimated than those of the intervention group.
However, as total societal costs were higher in the control group
than in the intervention group, it seems unlikely that the use of
retrospective questionnaires severely biased our results.
A second shortcoming of the present study was the inability to
include quality-adjusted life-years in the current economic evalu-
ation, because utilities of the control group were only measured at
one single time point.
A third shortcoming is the relatively short time horizon of the
clinical trial. Short time horizons are common in trial-based eco-
nomic evaluations, as longer follow-ups are typically not feasible
within a trial setting. One should bear in mind, however, that an
intervention’s cost-effectiveness observed within a trial may be
substantially different from its longer-term cost-effectiveness. To
deal with this limitation, the intervention’s longer-term cost-
effectiveness can be estimated using modelling techniques (48).
Finally, and inherent to all economic evaluations, is the fact
that the current results may not be generalizable to other coun-
tries due to differences in healthcare systems across countries.
Also, despite extensive efforts to limit the amount of missing
data, 56 percent of all participants had some missing cost data
and 24 percent had some missing effect data. Although missing
data are generally unavoidable in clinical studies and economic
evaluations in particular, and multiple imputation techniques
were used for filling in missing values, a complete dataset
would have produced more valid and reliable results.
Implications for Practice and Further Research
Decision makers can use the present results to consider whether
the TTCM provides “good value for money” at an acceptable
probability of cost-effectiveness. Implementation of the TTCM
in other level-1 trauma centers could be considered in the future,
although a multicenter controlled trial would be required to con-
firm the present results.
In conclusion, the TTCM may be cost-effective compared with
regular care, depending on the decision-makers willingness to pay
and the probability of cost-effectiveness that they perceive as
acceptable. However, a multicenter, and ideally randomized con-
trolled trial, would be preferred to fortify the results of this prag-
matic study.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0266462319000436
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